Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietins in Anemia of ESRD in Qatar
NCT02049346Phase 4Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Mar 2012
- Primary completion
- Apr 2013
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease, sponsored by Hamad Medical Corporation. Started Mar 2012; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT02049346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02049346.